SCHEMBL9508871

SCHEMBL9508871

CCOC(=O)COc1cccc2c(N(C)c3ccccc3)nc(Nc3ccccc3C)nc12

nearest known ligand 0.83

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9509707 0.91
SCHEMBL9508929 0.84
SCHEMBL9508862 0.84 MEN1 (0.56) MEN1KMT2A
SCHEMBL9508894 0.82
SCHEMBL9508925 0.81
Hydrochloric Acid SCHEMBL9776709 0.81
SCHEMBL9509700 0.79 MEN1 (0.50) MEN1KMT2A
SCHEMBL9508265 0.77
SCHEMBL9510904 0.75
SCHEMBL9776705 0.75 NPC1 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0404322-B1 QUINAZOLINE DERIVATIVES SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1993-09-22 EP disclosed
US-5064833-A Substituted quinazoline derivatives for use in gastrointestinal diseases SMITHKLINE BEECHAM INTERCREDIT B.V. (GB) 1991-11-12 US disclosed
EP-0404322-A1 Quinazoline derivatives SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1990-12-27 EP disclosed